S 18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases ACh release in the hippocampus of young and aged rat

Neuroscience Letters

Volumn 361, Issue 1-3, 2004, Pages 120-123

  Rosi, Susanna ^a,c   Giovannini, Maria Grazia ^a   Lestage, Pierre J ^b   Muñoz, Carmen ^b   Corte, Laura Della ^a   Pepeu, Giancarlo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Glutamate; Microdialysis; Passive avoidance test

Indexed keywords

2,3 DIHYDRO 3,4 CYCLOPENTANO 1,2,4 BENZOTHIADIAZINE 1,1 DIOXIDE; 2,3 DIHYDRO[3,4]CYCLOPENTANO 1,2,4 BENZOTHIADIAZINE 1,1 DIOXIDE; 4 AMINOBUTYRIC ACID; AMPA RECEPTOR AGONIST; GLUTAMIC ACID; SCOPOLAMINE; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; COGNITION; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; AGING; ANIMALS; AVOIDANCE LEARNING; BENZOTHIADIAZINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXTRACELLULAR FLUID; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HIPPOCAMPUS; MALE; MEMORY DISORDERS; MICRODIALYSIS; NOOTROPIC AGENTS; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, AMPA; SCOPOLAMINE; UP-REGULATION;

EID: 2342448516     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.12.061     Document Type: Article

References (20)

1. Arnaiz E., Almkvist O. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurol. Scand. 179:(Suppl.):2003;34-41
2. Bartolini L., Casamenti F., Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol. Biochem. Behav. 55:1996;277-283
3. Bianchi L., Della Corte L., Tipton K.F. Simultaneous fryrtmination of basal and evoked output levels of aspartate, glutamate, taurine, and γ-aminobutyric acid during microdialysis and from superfused brain slices. J. Chromatogr. B. Biomed. Sci. Appl. 737:1999;47-59
4. Drachman D.A., Leavitt J. Human memory and the cholinergic system: a relationship to ageing? Arch. Neurol. 30:1974;113-121
5. Giovannini M.G., Mutolo D., Bianchi L., Michelassi A., Pepeu G. NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study. J. Neurosci. 14:1994;1358-1365
6. Giovannini M.G., Rakovska A., Della Corte L., Bianchi L., Pepeu G. Activation of non-NMDA receptors stimulates acetylcholine and GABA release from dorsal hippocampus: a microdialysis study in the rat. Neurosci. Lett. 243:1998;152-156
7. Giovannini M.G., Rodinò P., Mutolo M., Pepeu G. Oxiracetam and aniracetam increase acetylcholine release from the rat hippocampus in vivo. Drug Dev. Res. 28:1993;503-509
8. Ito I., Tanabe S., Kohda A., Sugiyama H. Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J. Physiol. (Lond.). 424:1990;533-543
9. Lebrun C., Pilliere E., Lestage P. Effects of S 18986-1, a novel cognitive enhancer, on memory performances in an object recognition task in rats. Eur. J. Pharmacol. 401:2000;205-212
10. Lebrun C., Roger A., Pilliere E., Albinet K., Krentner M., Lestage P. S 18986, positive modulator of AMPA-type glutamate receptors, a novel cognitive enhancing agent. Soc. Neurosci. Abstr. 24:1998;98
11. Lobo A., Launer L.J., Fratiglioni L., Andersen K., Di Carlo A., Breteler M.M., Copeland J.R., Dartigues J.F., Jagger C., Martinez-Lage J., Soininen H., Hofman A. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology. 54:(Suppl. 5):2000;S4-S9
12. Pepeu G., Giovannelli L. The central cholinergic system during aging. In: F.E. Bloom (Ed.) Neuroscience: from the molecular to the cognitive. Prog. Brain Res. 100:1994;67-71
13. Sarter M., Bruno J.P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain. Res. Rev. 23:1997;28-46
14. Sarter M., Hagan J., Dudchenko P. Behavioral screening for cognition enhancers: from indiscriminate to valid tests. Psychopharmacology. 107:1992;144-159
15. Scali C., Giovannini M.G., Bartolini L., Prosperi C., Hinz V., Schmidt B., Pepeu G. Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats. Eur. J. Pharmacol. 325:1997;173-180
16. Shorvon S. Pyrrolidone derivatives. Lancet. 358:2001;1885-1892
17. Spignoli G., Pepeu G. Interactions between oxiracetam, aniracetam and scopolamine on behaviour and brain acetylcholine. Pharmacol. Biochem. Behav. 27:1987;491-495
18. Staubli U., Rogers G., Lynch G. Facilitation of glutamate receptors enhances memory. Proc. Natl. Acad. Sci. USA. 91:1994;777-781
19. Vannucchi M.G., Scali C., Kopf S.R., Pepeu G., Casamenti F. Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats. Neuroscience. 79:1997;837-846
20. Yu S., Cai J. The effects of aniracetam on extracellular levels of transmitter amino acids in the hippocampus of the conscious gerbils: an intracranial microdialysis study. Neurosci. Lett. 339:2003;187-190